Article

Essilor, Transitions offer customers a little TLC

Dallas-Essilor of America (EOA) now offers a combination of Crizal anti-reflective coatings and Transitions photochromic lenses for Total Light Control (TLC).

Dallas-Essilor of America (EOA) now offers a combination of Crizal anti-reflective coatings and Transitions photochromic lenses for Total Light Control (TLC).

According to the company, TLC "successfully controls light, providing patients with optimal vision."

"Light is central to good vision," said Carl Bracy, vice president of marketing for Essilor. "By communicating the benefits of Crizal and Transitions lenses together, we are able to offer our eye-care professionals and their patients the best overall lens performance, quality of vision, and the preservation and protection of the health and well-being of their eyes."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.